Biomaster Overview

  • Founded
  • 2002
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

Biomaster General Information

Description

Developer of regenerative medicines. The company's regenerative medicines include adipose derived stem cell, enabling the medical industry to increases the soft tissue of the body for fighting facial degenerative diseases.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Parent Company
Primary Office
  • Yokohama Excellent III 2nd Floor
  • 35th Minami-mer 3-chome Minami-ku
  • Yokohama-shi, 231-0006
  • Japan
+81 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Biomaster Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biomaster‘s full profile, request access.

Request a free trial

Biomaster Executive Team (1)

Name Title Board Seat Contact Info
Satoshi Nakatani President
To view Biomaster’s complete executive team members history, request access »

Biomaster Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biomaster‘s full profile, request access.

Request a free trial